Gamma Generalized Linear Models for Pharmacokinetic Data

This article considers the modeling of single-dose pharmacokinetic data. Traditionally, so-called compartmental models have been used to analyze such data. Unfortunately, the mean function of such models are sums of exponentials for which inference and computation may not be straightforward. We present an alternative to these models based on generalized linear models, for which desirable statistical properties exist, with a logarithmic link and gamma distribution. The latter has a constant coefficient of variation, which is often appropriate for pharmacokinetic data. Inference is convenient from either a likelihood or a Bayesian perspective. We consider models for both single and multiple individuals, the latter via generalized linear mixed models. For single individuals, Bayesian computation may be carried out with recourse to simulation. We describe a rejection algorithm that, unlike Markov chain Monte Carlo, produces independent samples from the posterior and allows straightforward calculation of Bayes factors for model comparison. We also illustrate how prior distributions may be specified in terms of model-free pharmacokinetic parameters of interest. The methods are applied to data from 12 individuals following administration of the antiasthmatic agent theophylline.

[1]  L. Sansom,et al.  Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults , 1982, Journal of Pharmacokinetics and Biopharmaceutics.

[2]  Jon Wakefield,et al.  Bayesian individualization via sampling-based methods , 1996, Journal of Pharmacokinetics and Biopharmaceutics.

[3]  Keith Godfrey,et al.  Compartmental Models and Their Application , 1983 .

[4]  N. G. Best,et al.  WinBUGS User Manual: Version 1.4 , 2001 .

[5]  L. Wasserman,et al.  Computing Bayes Factors by Combining Simulation and Asymptotic Approximations , 1997 .

[6]  M. Weiss Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. I. Log-convex drug disposition curves , 1986, Journal of Pharmacokinetics and Biopharmaceutics.

[7]  David J. Spiegelhalter,et al.  WinBUGS user manual version 1.4 , 2003 .

[8]  R. Kass,et al.  Bayes Factors and Approximations for Variance Component Models , 1999 .

[9]  L. Skovgaard NONLINEAR MODELS FOR REPEATED MEASUREMENT DATA. , 1996 .

[10]  Jon Wakefield,et al.  An Expected Loss Approach to the Design of Dosage Regimens Via Sampling‐Based Methods , 1994 .

[11]  J. Lindsey,et al.  Generalized Nonlinear Models for Pharmacokinetic Data , 2000, Biometrics.

[12]  M. Weiss Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. II. Log-concave concentration-time curves following oral administration , 1987, Journal of Pharmacokinetics and Biopharmaceutics.

[13]  A-5 Default Bayes Factors for Variance Component Models , 2002 .

[14]  Adrian F. M. Smith,et al.  Bayesian Analysis of Linear and Non‐Linear Population Models by Using the Gibbs Sampler , 1994 .

[15]  J. Wakefield NON-LINEAR REGRESSION MODELLING AND INFERENCE , 2004 .